Telehealth Ranker

How We Rank Telehealth Weight-Loss Programs | Telehealth Ranker

Disclosure

Short: We may have a financial affiliation with some entities featured on this page. Rankings are editorial; see our methodology.

Full: Telehealth Ranker is an independent educational publisher. We may have a financial affiliation with some entities featured on this site. Rank positions are determined by our published methodology. We do not provide medical care, diagnoses, or treatment.

Affiliation and rank: Financial affiliations do not guarantee a rank position. No program is locked into a predetermined slot. Affiliations are disclosed separately from scoring.

Medical disclaimer: Content on Telehealth Ranker is for educational purposes only and is not medical advice, diagnosis, or treatment. We are not a medical provider, pharmacy, or telehealth clinic. Always consult a licensed clinician. If you have a medical emergency, call 911 (US) or your local emergency number.

What this page is for

Telehealth Ranker publishes magazine-style rankings and explainers of U.S.-facing telehealth programs that help adults explore clinician-guided medical weight management — including pathways that may involve FDA-approved GLP-1 / dual-agonist therapies and, where offered, compounded formulations.

We are not a telehealth clinic, pharmacy, or booking portal. We do not diagnose, prescribe, or “start visits.” Outbound links use educational CTAs such as Visit site or Check eligibility.

Core rule: at least 10 programs

Every ranked roundup lists at least 10 named programs. Thin “top 3” marketing lists without a broader field do not meet our bar.

Wave 1 (as of September 23, 2026) publishes a numbered Top 10 under this methodology. Ranks are evidence-earned from the research snapshot and secondary criteria described below — not predetermined seals, endorsement badges, or paid locks. Google review cells remain TBD until live Maps/Business verification; we do not invent Google scores. Trustpilot figures are research snapshots (accessed September 15–16, 2026 ET); Mod/ops should re-verify live Trustpilot on publish day.

What we weigh most heavily

1. Trustpilot (primary review signal)

We capture, when verifiable:

  • TrustScore (e.g., 4.5 / 5)
  • Approximate review volume
  • Profile URL
  • Snapshot / access date
  • Qualitative notes on recency (lifetime scores with very few recent reviews get a caution flag)

Why it matters: Trustpilot is one of the few large, public, cross-brand consumer-experience datasets for telehealth brands. Higher scores with larger samples generally outrank thin high scores. Company-wide profiles (multi-product brands) are labeled as such so readers do not confuse a hair/ED/weight-loss conglomerate score with a weight-loss-only sample.

2. Google reviews (primary review signal, when verifiable)

We look for a stable public Google Business / Maps profile tied to the brand or weight-loss program. When we can verify:

  • Star rating
  • Review count
  • Profile identity notes
  • Access date

When we cannot verify a live Google rating at publish time, we mark TBD and do not invent numbers. Marketing claims on a brand’s own site are not treated as verified Google scores.

How review signals interact

Situation Editorial treatment
Strong Trustpilot score + large volume; Google TBD Eligible for high provisional weight; Google marked TBD
Similar Trustpilot scores Larger review base generally ranks higher
High lifetime score, sparse last-12-month activity Recency caution in copy; may lower relative weight
Conflicting secondary reports Prefer live Trustpilot/Google re-check; otherwise mark range or TBD
No public Trustpilot or Google Remains in 10 field with TBD review cells; other criteria still noted

Reviews measure reported service experience — not clinical efficacy, safety, or whether a drug is right for any individual.

Other criteria (secondary weight)

Beyond Trustpilot and Google, we score publicly observable signals:

Access model

  • Ongoing clinician messaging vs. one-off consults
  • Coaching or care-team structure
  • Brand-name vs. compounded medication pathways (described as educational context only)
  • Insurance navigation vs. cash-pay framing

Pricing clarity

  • Whether membership and medication are separated
  • Whether public pages explain what is included (labs, coaching, shipping)
  • Cancellation / commitment language as described publicly
  • We do not invent “starting at prices when live checkout or clear public pricing cannot be confirmed

Eligibility / fit information

  • Whether the program explains who may or may not be a candidate
  • State availability language
  • Clear distinction that eligibility is clinician-determined

Reported experience (beyond star averages)

  • Recurring praise and complaint themes in public reviews (billing, shipping, support, coaching)
  • Response patterns to negative reviews when visible
  • Relevant public regulatory context (e.g., FDA statements) cited to primary sources — never as a substitute for clinical advice

What we do not score

  • Paid placements or affiliation “boosts
  • Endorsement seals, “official partner” badges, or predetermined #1/#2 locks
  • Fabricated star ratings, review counts, prices, or patient quotes
  • Claims that any program is clinically superior for everyone
  • Influencer testimonials without a public review-platform anchor

How ranks are built (and how they change)

  1. Inventory U.S. telehealth medical weight-loss / GLP-1 programs with an identifiable public offering.
  2. Capture Trustpilot and Google signals with dates; mark TBD when live verification fails.
  3. Normalize volume and recency; apply secondary criteria from public pages.
  4. Publish a provisional/final numbered list of at least 10 programs, clearly labeled with an as-of date and methodology-linked.
  5. Update when review signals, offerings, pricing clarity, or regulatory context change materially.

Ranks can change. A program that leads on review volume today may move if scores shift, recency collapses, pricing opacity worsens, or competitors improve public experience signals. Financial affiliations do not freeze position.

Wave 1 Top 10 (as of September 23, 2026)

Numbered order reflects Trustpilot snapshot strength (score volume) plus secondary criteria under this methodology. Google: TBD for all rows. Figures are research snapshots from September 15–16, 2026 (ET); re-verify live Trustpilot on publish day.

Rank Program Trustpilot signal (snapshot) Google
1 Ivim Health (ivimhealth.com) ~4.9 / ~36K–39K TBD
2 Henry Meds (henrymeds.com) ~4.5 / ~12K+ TBD
3 Eden (tryeden.com) ~4.5 / ~3.7K4.7K TBD
4 Fridays (joinfridays.com) ~4.5 / ~4K TBD
5 Sesame Care (sesamecare.com) ~4.5 / ~3.9K TBD
6 Noom Med / Noom (noom.com) ~4.4–4.5 company-wide TBD
7 LifeMD (lifemd.com) ~4.1 / ~3.7K TBD
8 WeightWatchers Clinic (weightwatchers.com) ~4.0 / ~4.5K (may be broader WW) TBD
9 Ro / Ro Body (ro.co) ~3.73.9 / ~3K–5K TBD
10 Found (joinfound.com) ~3.6–3.8 / ~660–690 TBD

Ivim Health’s #1 slot is a methodology outcome from the strongest combined Trustpilot volume + score in this Wave 1 snapshot — not an endorsement seal, official #1” badge, or predetermined affiliate lock.

Evaluation pool notes (honorable mention)

Programs commonly evaluated for online medical weight-loss / GLP-1 telehealth roundups also include Calibrate (joincalibrate.com) and Hims & Hers (hims.com weight-loss pathway). They remain in the broader evaluation pool and may appear in honorable-mention notes when useful. Wave 1’s locked Top 10 slots are the ten programs in the table above. Inclusion in the pool or Top 10 is not an endorsement.

Compounded vs. FDA-approved context (educational)

Some programs discuss FDA-approved brand products; others also discuss compounded formulations. Compounded drugs are not FDA-approved as equivalent copies of brand GLP-1 products. As national supply has stabilized, FDA has clarified compounding limits under sections 503A and 503B of the FD&C Act. We summarize regulatory context for readers; we do not instruct compounders or clinics, and we do not treat any ranking as regulatory clearance. Discuss formulation type, pharmacy source, and monitoring with a licensed clinician.

Methodology footer stub (for ranking templates)

We score programs on transparent criteria published in our methodology. Trustpilot reviews and Google reviews are heavily weighted. We also consider access model, pricing clarity, eligibility/fit information, and other reported experience signals. Rankings list at least 10 programs. Rank order can change when evidence or offerings change. Financial affiliations are disclosed separately and do not guarantee a rank position.

Methodology last reviewed: September 23, 2026 · Read full methodology →

Contact / corrections

Editorial corrections to review snapshots, program names, or broken methodology links: use the site Contact page. We prefer primary Trustpilot/Google URLs and access dates over unsourced screenshots.